You just read:

Janssen Announces the Initiation of Two Studies Evaluating Daratumumab (DARZALEX®) and Atezolizumab in Multiple Myeloma and Solid Tumor

News provided by

Janssen Research & Development, LLC

Mar 21, 2016, 13:17 ET